Prevention of pericarditis with colchicine: An updated meta-analysis

Journal of Cardiovascular Medicine

Volumn 16, Issue 2, 2015, Pages 144-147

  Briasoulis, Alexandros ^a   Afonso, Luis ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DABIGATRAN; DABIGATRAN ETEXILATE; PLACEBO; WARFARIN; COLCHICINE;

CONGESTIVE HEART FAILURE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART LEFT VENTRICLE; HUMAN; LETTER; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RANDOMIZATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERICARDITIS; PRIMARY PREVENTION; PROCEDURES; SECONDARY PREVENTION;

COLCHICINE; HUMANS; PERICARDITIS; PRIMARY PREVENTION; SECONDARY PREVENTION;

EID: 84920713816     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000237     Document Type: Letter

References (2)

1. Imazio M, Brucato A, Belli R, et al. Colchicine for the prevention of pericarditis: what we know and what we do not know in 2014: systematic review and metaanalysis. J Cardiovasc Med (Hagerstown) 2014 [Epub ahead of print].
2. Imazio M, Brucato A, Ferrazzi P, et al. For the COPPS-2 Investigators. Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial. JAMA 2014; 312:1016-1023.